FASN-IN-3

FASN-IN-3 is a fatty acid synthase (FASN) inhibitor extracted from patent US20170119786A1, compound 242A[1].

Product Specifications

CAS Number

[2097262-60-5]

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Fatty Acid Synthase (FASN)

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/Heterocyclic_modulators_1.html

Purity

98.06

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

N#CC1=CC=C(C2CN(C(C3=CC(C4=C(C)C(C)=NN4)=C(C)C=C3C)=O)C2)C=C1

Molecular Formula

C24H24N4O

Molecular Weight

384.47

Precautions

H302, H315, H319, H335

References & Citations

[1]Buckley, Douglas I, et al. HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS. US20170119786A1

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

42506111 3x 1.0 µg

RPS3AP19 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

View Details

PV217080 500 ng

PLEKHB1 Protein Vector (Mouse) (pPM-C-HA)

View Details

NBP3-06047AF488 0.1 mL

Rabbit Polyclonal KLHL17 Antibody [Alexa Fluor 488]

View Details

B2175-14 2.5 mg

5,7-Bis- (benzyloxy) -a- (4- (benzyloxy) phenyl) -3-[3,4-di-O-acetyl-a-O-acetyl-a-L-rhamnopyranosyloxyl]-4H-chromen-4-one

View Details

MBS6050357-01 25 g

Homoveratronitrile

View Details

MBS6050357-02 5x 25 g

Homoveratronitrile

View Details